The randomized PICSO-AMI-I trial: pressure-controlled intermittent coronary sinus occlusion in acute myocardial infarction

Reported from TCT 2023

Aaysha Cader interviews Giovanni Luigi De Maria about the results of the PICSO-AMI-I Trial which he presented during the TCT Congress 2023 in San Francisco.

The results of this first multicenter, prospective randomized trial of pressure controlled intermittent coronary sinus occlusion (PiCSO) therapy used in conjunction with primary PCI indicated that it did not reduce myocardial infarct size in patients with anterior ST-segment elevation myocardial infarction (STEMI).